medicine

The faculty members have published research that is cited most often by other scholars in their fields.

Three UCLA student veterans share their stories of immigration and their passion for medical science.

UCLA’s new Rosenfeld Hall will play a pivotal role in training the next generation of medical professionals and improving care for patients.

The facility was made possible by a $20 million gift from donors Eugene and Maxine Rosenfeld.

A UCLA study shows that in 2022, nearly half of California adults had used these services over the previous year.

An advance in cryo-electron microscopy could be a significant boon for research on potential cancer therapies.

A study co-led by UCLA is the first clinical trial analyzing a targeted therapy specifically developed to treat brain tumors.

New research shows that the accuracy of genetically based disease predictions varies from person to person.

Through his research and volunteering, the graduating senior and future medical student has already made an impact.

The annual list compiled by Clarivate identifies scholars whose work has been referenced most often in studies published by other researchers.

Research brief: In a lab study, a UCLA-led team found that verteporfin stopped the replication of SARS-CoV-2, the virus that causes COVID-19.

Past injustices like the Tuskegee Syphilis Study are less likely to spark mistrust than poor interactions with physicians, UCLA psychologists say.

Inspired by creatures that survive in harsh environments, a UCLA team has invented a polymer with the potential to extend the shelf life and reach of medications.

Aparna Bhaduri is leading the fight against the deadliest form of cancer.

The two grant projects, funded by the National Institutes of Health and the Department of Defense, will be led by Dr. Jerzy Kupiec-Weglinski.

With stories from across campus, we pay tribute to some of UCLA’s remarkable graduating students.

The advance could have implications for drug development and biological research.

The oral medication, ERAS-801, targets a rogue gene found in about 60% of people with the aggressive form of brain cancer.

Dr. Haig Aintablian, who recently completed his residency in emergency medicine at UCLA, is the program’s inaugural fellow.

Research brief: Six months after the shot, nearly 96% of study participants in North Kivu Province still had antibodies in their blood.

Research brief: Additional services to monitor the drug’s potential side effects account for nearly 20% of its total costs, a UCLA-led study shows.

The UCLA–developed diagnostic technology has helped keep the university and other large client organizations operational during the pandemic.

Chancellor Gene Block tours the COVID-19 testing lab, as processes automate and capacity expands.

Bruin Carly Daniels, who leads the Pfizer scientists developing vaccines for pneumonia and the coronavirus, always remembers that patients are waiting.

The five-year award from California’s stem cell agency will help prepare young scientists and physicians to become leaders in the regenerative medicine field.